Krastina S. K.
- Country
- Bulgaria
- Department
- Clinic of Pediatrics Level III
Research Overview
- Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib in Children and Adolescents with Polyarticular-Course Juvenile Idiopathic Arthritis
- Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Pediatric Patients with Active Juvenile Psoriatic Arthritis: A Phase 3 Randomized Withdrawal Study
Data & Insights
Has run more than one trial at 7 of 48 partner sites.
Specializations
Pediatric Rheumatology
The investigator specializes in the treatment and research of juvenile psoriatic arthritis (JPsA), focusing on innovative therapeutic approaches for young patients aged 5 to 18 years.
- Pediatric Autoimmune Disorders
- Inflammatory Joint Conditions
- Childhood Rheumatic Diseases
The investigator evaluates advanced therapeutic options for managing pediatric rheumatic conditions.
Immunology
The investigator's work centers on immune-mediated inflammatory conditions in pediatric populations, with particular attention to novel immunomodulatory treatments.
- Autoimmune Response
- Inflammatory Pathways
- Immune System Modulation
Their research encompasses the evaluation of targeted therapies for autoimmune conditions in children.
Pediatric Clinical Care
The investigator focuses on developing therapeutic strategies for chronic inflammatory conditions affecting pediatric patients.
- Quality of Life Assessment
- Long-term Disease Management
- Pediatric Treatment Safety
Their work includes evaluating treatment responses in young patients with chronic inflammatory arthritis.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.